MSH|^~\&|LAB|RCH|||201911081335||ORU^R01|4103126|D|2.3|||AL|NE
PID|1||RC00007850|RC7597|LABTEST^FLUID^CHECK||19440615|M||||||||||RC000574/19|9875062519
OBR|1|35026^LAB|00026891^0811:HC00001R^LAB^081119:HC1^35026|220.8900^INR^INR^^^6301-6||201911081053|201911081053|||||||201911081053||||||||||LAB|F||||
OBX|1|ST|220.9000^INR R^INR^^6301-6^6301-6|1|1.0^^Y||0.8-1.2|N||A^S|F|||201911081057
NTE|1||INR Therapeutic Ranges:
NTE|2||    Mechanical Heart Valves 2.5 - 3.5
NTE|3||    Other indications       2.0 - 3.0
OBR|2|35026^LAB|00026891^0811:HC00001R^LAB^081119:HC1^35026|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9||201911081053|201911081053|||||||201911081053||||||||||LAB|F||||
OBX|1|ST|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9|1|31^^Y|s|23-32|N||A^S|F|||201911081057
NTE|1||Note: New reference range as of Sept 18, 2019
NTE|2||
NTE|3||New Therapeutic Range for FULL DOSE Unfractionated Heparin:
NTE|4||60 - 90 secs
NTE|5||For low dose and other indications, refer to appropriate
NTE|6||nomograms.
NTE|7||
NTE|8||Note: The previous full dose unfractionated heparin
NTE|9||therapeutic range was 75-99 secs
OBR|3|35026^LAB|00026891^0811:HC00001R^LAB^081119:HC1^35026|231.2500^PF4^Anti-Platelet Factor 4 Group^^^34701-3||201911081053|201911081053|||||||201911081053||||||||||LAB|F||||
OBX|1|ST|231.2485^HIT R^Platelet PF4 Antibodies^^45155-9^|1|<1.0^^Y|U/mL|<1.0|N||A^S|F|||201911081335
NTE|1||HIT Screen Negative.

MSH|^~\&|LAB|SMH|||201911081335||ORU^R01|4103127|D|2.3|||AL|NE
PID|1||SM00044878|SM44684|LABTEST^MAYFLOWER^||20181204|M||||||||||SM000861/19|9875311264
OBR|1|35029^LAB|00026894^0811:HC00004R^LAB^081119:HC4^35029|220.8900^INR^INR^^^6301-6||201911081057|201911081055|||||||201911081055||||||||||LAB|I||||
OBR|2|35029^LAB|00026894^0811:HC00004R^LAB^081119:HC4^35029|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9||201911081057|201911081055|||||||201911081055||||||||||LAB|I||||
OBR|3|35029^LAB|00026894^0811:HC00004R^LAB^081119:HC4^35029|231.2500^PF4^Anti-Platelet Factor 4 Group^^^34701-3||201911081057|201911081055|||||||201911081055||||||||||LAB|F||||
OBX|1|ST|231.2485^HIT R^Platelet PF4 Antibodies^^45155-9^|1|<1.0^^Y|U/mL|<1.0|N||A^S|F|||201911081335
NTE|1||HIT Screen Negative.

MSH|^~\&|LAB|RCH|||201911081335||ORU^R01|4103128|D|2.3|||AL|NE
PID|1||RC00007906|RC7654|LABTEST^NOTWITHSTANDING^||19450216|F||||||||||RC000693/19|9874962579
OBR|1|35030^LAB|00026895^0811:HC00005R^LAB^081119:HC5^35030|220.8900^INR^INR^^^6301-6||201911081058|201911081058|||||||201911081058||||||||||LAB|I||||
OBR|2|35030^LAB|00026895^0811:HC00005R^LAB^081119:HC5^35030|220.9600^PTT^Partial Thromboplastin Time^^14979-9^14979-9||201911081058|201911081058|||||||201911081058||||||||||LAB|I||||
OBR|3|35030^LAB|00026895^0811:HC00005R^LAB^081119:HC5^35030|231.2500^PF4^Anti-Platelet Factor 4 Group^^^34701-3||201911081058|201911081058|||||||201911081058||||||||||LAB|I||||
OBX|1|ST|231.2485^HIT R^Platelet PF4 Antibodies^^45155-9^|1|1.0^^Y|U/mL|<1.0|H||A^S|F|||201911081335
NTE|1||* CRITICAL VALUE
NTE|2||This assay has a sensitivity of at least 95% and a
NTE|3||specificity of 75% at the 1.0 U/mL cut-off.  For results
NTE|4||>4.0 U/mL the specificity is 95%. HIT remains a clinical
NTE|5||diagnosis and results should be interpreted using the 4T's
NTE|6||probability score.

MSH|^~\&|LAB|SMH|||201911081336||ORU^R01|4103130|D|2.3|||AL|NE
PID|1||SM00045197|SM44995|LABTEST^FRESHIE^||20190109|M||||||||||SM001297/19|
OBR|1|35027^LAB|00026892^0811:HC00002R^LAB^081119:HC2^35027|231.2500^PF4^Anti-Platelet Factor 4 Group^^^34701-3||201911081054|201911081053|||||||201911081054||||||||||LAB|F||||
OBX|1|ST|231.2485^HIT R^Platelet PF4 Antibodies^^45155-9^|1|<1.0^^Y|U/mL|<1.0|N||A^S|F|||201911081336
NTE|1||HIT Screen Negative.

MSH|^~\&|LAB|RCH|||201911081336||ORU^R01|4103131|D|2.3|||AL|NE
PID|1||RC00007909|RC7657|LABTEST^GOING^TOTEST||19440615|F||||||||||RC000696/19|9874962522
OBR|1|35028^LAB|00026893^0811:HC00003R^LAB^081119:HC3^35028|231.2500^PF4^Anti-Platelet Factor 4 Group^^^34701-3||201911081055|201911081054|||||||201911081055||||||||||LAB|F||||
OBX|1|ST|231.2485^HIT R^Platelet PF4 Antibodies^^45155-9^|1|<1.0^^Y|U/mL|<1.0|N||A^S|F|||201911081336
NTE|1||HIT Screen Negative.

MSH|^~\&|LAB|SMH|||201911081336||ORU^R01|4103132|D|2.3|||AL|NE
PID|1||SM00044209|SM44044|LABTEST^SIMPLE^TEE||19770415|F||||||||||SM005131/18|9875454996
OBR|1|35033^LAB|00026898^0811:HC00007R^LAB^081119:HC7^35033|231.2500^PF4^Anti-Platelet Factor 4 Group^^^34701-3||201911081144|201911081144|||||||201911081144||||||||||LAB|F||||
OBX|1|ST|231.2485^HIT R^Platelet PF4 Antibodies^^45155-9^|1|<1.0^^Y|U/mL|<1.0|N||A^S|F|||201911081336
NTE|1||HIT Screen Negative.